Onyx Biotec Ltd. (OBL), a pharmaceutical company specializing in sterile water for injections, is making its debut on the ...

Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross profit increased from ($20 thousand) to $24 thousand. WA ...

Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the ...

Batch management plays a crucial role in the life sciences industry, ensuring quality, compliance, and traceability. Learn ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

CRISPR Therapeutics ( CRSP -5.91%) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

Hyderabad: Granules India Limited, a pharmaceutical company, has announced that it has received the Golden Peacock Award for ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

The new facility is expected to create more than 800 jobs over the next five years, with 291 jobs coming within the initial two-year ramp-up window (per the PILOT). The company will spend $93 million ...

Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...